Cannabinoid receptor agonist as an alternative drug in5-fluorouracil- resistant gastric cancer cells

Anticancer Research

Volumn 33, Issue 6, 2013, Pages 2541-2548

  Xian, Xiang Shu ^a,b   ChoiPark, Hyeyeon ^a   Choi, Myung Gyu ^a   Park, Jae Myung ^a  

^a The Catholic University of Korea   (South Korea)

^b YANTAI YUHUANGDING HOSPITAL   (China)

Author keywords

Apoptosis; Cannabinoids; Drug resistance; Fluorouracil; Gastric cancer

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; CASPASE 3; FLUOROURACIL; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BAX; PROTEIN KINASE B; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIMETABOLITE; BENZOXAZINE DERIVATIVE; CANNABINOID; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR AGONIST; MITOGEN ACTIVATED PROTEIN KINASE; MORPHOLINE DERIVATIVE; NAPHTHALENE DERIVATIVE; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CANCER SURVIVAL; CELL CYCLE ARREST; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CANCER; DRUG EFFECT; DRUG RESISTANCE; METABOLISM; STOMACH TUMOR; TUMOR CELL LINE;

APOPTOSIS; CANNABINOIDS; DRUG RESISTANCE; FLUOROURACIL; GASTRIC CANCER;

ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BENZOXAZINES; CANNABINOID RECEPTOR AGONISTS; CASPASE 3; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DRUG RESISTANCE, NEOPLASM; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLUOROURACIL; HUMANS; MORPHOLINES; NAPHTHALENES; POLY(ADP-RIBOSE) POLYMERASES; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, CANNABINOID; STOMACH NEOPLASMS;

MLCS; MLOWN;

EID: 84881329701     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics, 2011. CA Cancer J Clin 61: 59-90, 2011.
2. Ajani JA: Standard chemotherapy for gastric carcinoma: Is it a myth? J Clin Oncol 18: 4001-4003, 2000.
3. Pasini F, Fraccon AP and DE Manzoni G: The role of chemotherapy in metastatic gastric cancer. Anticancer Res 31: 3543-3554, 2011.
4. Toffoli G and Cecchin E: Pharmacogenetics of stomach cancer. Suppl Tumori 2: S19-22, 2003.
5. Thomas DM and Zalcberg JR: 5-Fluorouracil: A pharmacological paradigm in the use of cytotoxics. Clin Exp Pharmacol Physiol 25: 887-895, 1998.
6. Guzman M: Cannabinoids: potential anticancer agents. Nat Rev Cancer 3: 745-755, 2003.
7. Carracedo A, Gironella M, Lorente M, Garcia S, Guzman M, Velasco G and Iovanna JL: Cannabinoids induce apoptosis of pancreatic tumor cells via endoplasmic reticulum stress-related genes. Cancer Res 66: 6748-6755, 2006.
8. Carracedo A, Lorente M, Egia A, Blazquez C, Garcia S, Giroux V, Malicet C, Villuendas R, Gironella M, Gonzalez-Feria L, Piris MA, Iovanna JL, Guzman M and Velasco G: The stressregulated protein p8 mediates cannabinoid-induced apoptosis of tumor cells. Cancer Cell 9: 301-312, 2006.
9. Gustafsson K, Christensson B, Sander B and Flygare J: Cannabinoid receptor-mediated apoptosis induced by R(+)-methanandamide and Win55,212-2 is associated with ceramide accumulation and p38 activation in mantle cell lymphoma. Mol Pharmacol 70: 1612-1620, 2006.
10. Ligresti A, Moriello AS, Starowicz K, Matias I, Pisanti S, De Petrocellis L, Laezza C, Portella G, Bifulco M and Di Marzo V: Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma. J Pharmacol Exp Ther 318: 1375-1387, 2006.
11. Sarfaraz S, Afaq F, Adhami VM, Malik A and Mukhtar H: Cannabinoid receptor agonist-induced apoptosis of human prostate cancer cells LNCaP proceeds through sustained activation of ERK1/2 leading to G1 cell cycle arrest. J Biol Chem 281: 39480-39491, 2006.
12. Greenhough A, Patsos HA, Williams AC and Paraskeva C: The cannabinoid delta(9)-tetrahydrocannabinol inhibits RAS-MAPK and PI3K-AKT survival signalling and induces BAD-mediated apoptosis in colorectal cancer cells. Int J Cancer 121: 2172-2180, 2007.
13. Ligresti A, Bisogno T, Matias I, De Petrocellis L, Cascio MG, Cosenza V, D'Argenio G, Scaglione G, Bifulco M, Sorrentini I and Di Marzo V: Possible endocannabinoid control of colorectal cancer growth. Gastroenterology 125: 677-687, 2003.
14. Patsos HA, Hicks DJ, Dobson RR, Greenhough A, Woodman N, Lane JD, Williams AC and Paraskeva C: The endogenous cannabinoid, anandamide, induces cell death in colorectal carcinoma cells: A possible role for cyclooxygenase 2. Gut 54: 1741-1750, 2005.
15. Sreevalsan S, Joseph S, Jutooru I, Chadalapaka G and Safe SH: Induction of apoptosis by cannabinoids in prostate and colon cancer cells is phosphatase dependent. Anticancer Res 31: 3799-3807, 2011.
16. Miyato H, Kitayama J, Yamashita H, Souma D, Asakage M, Yamada J and Nagawa H: Pharmacological synergism between cannabinoids and paclitaxel in gastric cancer cell lines. J Surg Res 155: 40-47, 2009.
17. Park JM, Xian XS, Choi MG, Park H, Cho YK, Lee IS, Kim SW and Chung IS: Antiproliferative mechanism of a cannabinoid agonist by cell cycle arrest in human gastric cancer cells. J Cell Biochem 112: 1192-1205, 2011.
18. Xian XS, Park H, Cho YK, Lee IS, Kim SW, Choi MG, Chung IS, Han KH and Park JM: Effect of a synthetic cannabinoid agonist on the proliferation and invasion of gastric cancer cells. J Cell Biochem 110: 321-332, 2010.
19. Galve-Roperh I, Sanchez C, Cortes ML, Gomez del Pulgar T, Izquierdo M and Guzman M: Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation. Nat Med 6: 313-319, 2000.
20. Eichele K, Weinzierl U, Ramer R, Brune K and Hinz B: R(+)-methanandamide elicits a cyclooxygenase-2-dependent mitochondrial apoptosis signaling pathway in human neuroglioma cells. Pharm Res 23: 90-94, 2006.
21. Oltersdorf T, Elmore SW, Shoemaker AR, Armstrong RC, Augeri DJ, Belli BA, Bruncko M, Deckwerth TL, Dinges J, Hajduk PJ, Joseph MK, Kitada S, Korsmeyer SJ, Kunzer AR, Letai A, Li C, Mitten MJ, Nettesheim DG, Ng S, Nimmer PM, O'Connor JM, Oleksijew A, Petros AM, Reed JC, Shen W, Tahir SK, Thompson CB, Tomaselli KJ, Wang B, Wendt MD, Zhang H, Fesik SW and Rosenberg SH: An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature 435: 677-681, 2005.
22. Giuliano M, Pellerito O, Portanova P, Calvaruso G, Santulli A, De Blasio A, Vento R and Tesoriere G: Apoptosis induced in HepG2 cells by the synthetic cannabinoid WIN: involvement of the transcription factor PPARgamma. Biochimie 91: 457-465, 2009.
23. Espada L, Meo-Evoli N, Sancho P, Real S, Fabregat I, Ambrosio S and Tauler A: ROS production is essential for the apoptotic function of E2F1 in pheochromocytoma and neuroblastoma cell lines. PloS one 7: e51544, 2012.